Rituximab Administration within 6 months of T cell-Depleted Allogeneic SCT is Associated with Prolonged Life-threatening Cytopenias

The monoclonal anti CD20 antibody Rituximab (RTX) is increasingly used in allogeneic stem cell transplantation (SCT) to treat lymphoproliferative disorders and chronic graft-versus-host disease (GVHD). RTX administration can be complicated by delayed and prolonged neutropenia, but the mechanism is u...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: McIver, Zachariah, Stephens, Nicole, Grim, Andrew, Barrett, A. John
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2947610/
https://ncbi.nlm.nih.gov/pubmed/20580848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.05.004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky